Last 12 months
Inside the activity.
1 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2025 Filed Mar 4, 2025 16:10 UTC |
Pine Matthew FrancisDirector · Pres. & CEO
|
GrantCommon Stock | 3,026 | $129.78 | $392,714.28 |
DisclosureSEC source: 0001562180-25-001951 · primarydocument.xml · nonDerivative · entry 2 Pine Matthew Francis · CIK 0001807057 · Director · Pres. & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,317 F3 · shares: Reflects the acquisition of 3,026 shares of common stock upon vesting of performance-based stock units granted on March 1, 2022 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ROIC. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 16:10 UTC |
Pine Matthew FrancisDirector · Pres. & CEO
|
GrantCommon Stock | 2,524 | $129.78 | $327,564.72 |
DisclosureSEC source: 0001562180-25-001951 · primarydocument.xml · nonDerivative · entry 1 Pine Matthew Francis · CIK 0001807057 · Director · Pres. & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,291 F1 · shares: Reflects the acquisition of 2,524 shares of common stock upon vesting of performance-based stock units granted on March 1, 2022 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:10 UTC |
Grogan William KSVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 396 | $129.78 | $51,392.88 |
DisclosureSEC source: 0001562180-25-001953 · primarydocument.xml · nonDerivative · entry 1 Grogan William K · CIK 0001694002 · SVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,077 F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2024 (396) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 16:12 UTC |
Toussaint Claudia SSVP, CPSO
|
Tax withholdingCommon Stock | 1,037 | $129.78 | $134,581.86 |
DisclosureSEC source: 0001562180-25-001960 · primarydocument.xml · nonDerivative · entry 5 Toussaint Claudia S · CIK 0001421560 · SVP, CPSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,112 F6 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2022 (435), March 1, 2023 (336), and March 1, 2024 (266) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 16:12 UTC |
Toussaint Claudia SSVP, CPSO
|
Tax withholdingCommon Stock | 2,203 | $129.78 | $285,905.34 |
DisclosureSEC source: 0001562180-25-001960 · primarydocument.xml · nonDerivative · entry 4 Toussaint Claudia S · CIK 0001421560 · SVP, CPSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,149 F5 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2022 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016). Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 16:12 UTC |
Toussaint Claudia SSVP, CPSO
|
GrantCommon Stock | 2,522 | $129.78 | $327,305.16 |
DisclosureSEC source: 0001562180-25-001960 · primarydocument.xml · nonDerivative · entry 3 Toussaint Claudia S · CIK 0001421560 · SVP, CPSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,352 F4 · shares: Reflects the acquisition of 2,522 shares of common stock upon vesting of performance-based stock units granted on March 1, 2022 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 16:12 UTC |
Toussaint Claudia SSVP, CPSO
|
GrantCommon Stock | 2,522 | $129.78 | $327,305.16 |
DisclosureSEC source: 0001562180-25-001960 · primarydocument.xml · nonDerivative · entry 2 Toussaint Claudia S · CIK 0001421560 · SVP, CPSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,830 F3 · shares: Reflects the acquisition of 2,522 shares of common stock upon vesting of performance-based stock units granted on March 1, 2022 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ROIC. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 16:12 UTC |
Toussaint Claudia SSVP, CPSO
|
GrantCommon Stock | 2,104 | $129.78 | $273,057.12 |
DisclosureSEC source: 0001562180-25-001960 · primarydocument.xml · nonDerivative · entry 1 Toussaint Claudia S · CIK 0001421560 · SVP, CPSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,308 F1 · shares: Reflects the acquisition of 2,104 shares of common stock upon vesting of performance-based stock units granted on March 1, 2022 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:13 UTC |
McShane Geri-MichelleVP, Controller & CAO
|
Tax withholdingCommon Stock | 236 | $129.78 | $30,628.08 |
DisclosureSEC source: 0001562180-25-001964 · primarydocument.xml · nonDerivative · entry 5 McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,420 F6 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2022 (87), March 1, 2023 (82), and March 1, 2024 (67) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:13 UTC |
McShane Geri-MichelleVP, Controller & CAO
|
Tax withholdingCommon Stock | 687 | $129.78 | $89,158.86 |
DisclosureSEC source: 0001562180-25-001964 · primarydocument.xml · nonDerivative · entry 4 McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,656 F5 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2022 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016). Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:13 UTC |
McShane Geri-MichelleVP, Controller & CAO
|
GrantCommon Stock | 630 | $129.78 | $81,761.40 |
DisclosureSEC source: 0001562180-25-001964 · primarydocument.xml · nonDerivative · entry 3 McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,343 F4 · shares: Reflects the acquisition of 630 shares of common stock upon vesting of performance-based stock units granted on March 1, 2022 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:13 UTC |
McShane Geri-MichelleVP, Controller & CAO
|
GrantCommon Stock | 630 | $129.78 | $81,761.40 |
DisclosureSEC source: 0001562180-25-001964 · primarydocument.xml · nonDerivative · entry 2 McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,713 F3 · shares: Reflects the acquisition of 630 shares of common stock upon vesting of performance-based stock units granted on March 1, 2022 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ROIC. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:13 UTC |
McShane Geri-MichelleVP, Controller & CAO
|
GrantCommon Stock | 526 | $129.78 | $68,264.28 |
DisclosureSEC source: 0001562180-25-001964 · primarydocument.xml · nonDerivative · entry 1 McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,083 F1 · shares: Reflects the acquisition of 526 shares of common stock upon vesting of performance-based stock units granted on March 1, 2022 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:14 UTC |
Yarkadas HayatiSVP & President, EU, WI & GLS
|
Tax withholdingCommon Stock | 179 | $129.78 | $23,230.62 |
DisclosureSEC source: 0001562180-25-001970 · primarydocument.xml · nonDerivative · entry 5 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,302 F6 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2022 (62), March 1, 2023 (75), and March 1, 2024 (42) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:14 UTC |
Yarkadas HayatiSVP & President, EU, WI & GLS
|
Tax withholdingCommon Stock | 456 | $129.78 | $59,179.68 |
DisclosureSEC source: 0001562180-25-001970 · primarydocument.xml · nonDerivative · entry 4 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,481 F5 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2022 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016). Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:14 UTC |
Yarkadas HayatiSVP & President, EU, WI & GLS
|
GrantCommon Stock | 3,026 | $129.78 | $392,714.28 |
DisclosureSEC source: 0001562180-25-001970 · primarydocument.xml · nonDerivative · entry 3 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,937 F4 · shares: Reflects the acquisition of 3,026 shares of common stock upon vesting of performance-based stock units granted on March 1, 2022 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:14 UTC |
Yarkadas HayatiSVP & President, EU, WI & GLS
|
GrantCommon Stock | 3,026 | $129.78 | $392,714.28 |
DisclosureSEC source: 0001562180-25-001970 · primarydocument.xml · nonDerivative · entry 2 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,911 F3 · shares: Reflects the acquisition of 3,026 shares of common stock upon vesting of performance-based stock units granted on March 1, 2022 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ROIC. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:14 UTC |
Yarkadas HayatiSVP & President, EU, WI & GLS
|
GrantCommon Stock | 2,524 | $129.78 | $327,564.72 |
DisclosureSEC source: 0001562180-25-001970 · primarydocument.xml · nonDerivative · entry 1 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,885 F1 · shares: Reflects the acquisition of 2,524 shares of common stock upon vesting of performance-based stock units granted on March 1, 2022 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:13 UTC |
Cho AlbertSVP, Strategy
|
Tax withholdingCommon Stock | 379 | $129.78 | $49,186.62 |
DisclosureSEC source: 0001562180-25-001963 · primarydocument.xml · nonDerivative · entry 5 Cho Albert · CIK 0002025025 · SVP, Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,910 F6 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2022 (119), March 1, 2023 (145), and March 1, 2024 (115) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:13 UTC |
Cho AlbertSVP, Strategy
|
Tax withholdingCommon Stock | 918 | $129.78 | $119,138.04 |
DisclosureSEC source: 0001562180-25-001963 · primarydocument.xml · nonDerivative · entry 4 Cho Albert · CIK 0002025025 · SVP, Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,289 F5 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2022 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016). Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:13 UTC |
Cho AlbertSVP, Strategy
|
GrantCommon Stock | 882 | $129.78 | $114,465.96 |
DisclosureSEC source: 0001562180-25-001963 · primarydocument.xml · nonDerivative · entry 3 Cho Albert · CIK 0002025025 · SVP, Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,207 F4 · shares: Reflects the acquisition of 882 shares of common stock upon vesting of performance-based stock units granted on March 1, 2022 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:13 UTC |
Cho AlbertSVP, Strategy
|
GrantCommon Stock | 882 | $129.78 | $114,465.96 |
DisclosureSEC source: 0001562180-25-001963 · primarydocument.xml · nonDerivative · entry 2 Cho Albert · CIK 0002025025 · SVP, Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,325 F3 · shares: Reflects the acquisition of 882 shares of common stock upon vesting of performance-based stock units granted on March 1, 2022 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ROIC. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:13 UTC |
Cho AlbertSVP, Strategy
|
GrantCommon Stock | 737 | $129.78 | $95,647.86 |
DisclosureSEC source: 0001562180-25-001963 · primarydocument.xml · nonDerivative · entry 1 Cho Albert · CIK 0002025025 · SVP, Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,443 F1 · shares: Reflects the acquisition of 737 shares of common stock upon vesting of performance-based stock units granted on March 1, 2022 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:13 UTC |
Capers Dorothy TrefonSVP & General Counsel
|
Tax withholdingCommon Stock | 816 | $129.78 | $105,900.48 |
DisclosureSEC source: 0001562180-25-001961 · primarydocument.xml · nonDerivative · entry 5 Capers Dorothy Trefon · CIK 0001905353 · SVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,015 F6 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2022 (458), March 1, 2023 (200), and March 1, 2024 (158) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:13 UTC |
Capers Dorothy TrefonSVP & General Counsel
|
Tax withholdingCommon Stock | 1,516 | $129.78 | $196,746.48 |
DisclosureSEC source: 0001562180-25-001961 · primarydocument.xml · nonDerivative · entry 4 Capers Dorothy Trefon · CIK 0001905353 · SVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,831 F5 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2022 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016). Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:13 UTC |
Capers Dorothy TrefonSVP & General Counsel
|
GrantCommon Stock | 1,575 | $129.78 | $204,403.50 |
DisclosureSEC source: 0001562180-25-001961 · primarydocument.xml · nonDerivative · entry 3 Capers Dorothy Trefon · CIK 0001905353 · SVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,347 F4 · shares: Reflects the acquisition of 1,575 shares of common stock upon vesting of performance-based stock units granted on March 1, 2022 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:13 UTC |
Capers Dorothy TrefonSVP & General Counsel
|
GrantCommon Stock | 1,575 | $129.78 | $204,403.50 |
DisclosureSEC source: 0001562180-25-001961 · primarydocument.xml · nonDerivative · entry 2 Capers Dorothy Trefon · CIK 0001905353 · SVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,772 F3 · shares: Reflects the acquisition of 1,575 shares of common stock upon vesting of performance-based stock units granted on March 1, 2022 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ROIC. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:13 UTC |
Capers Dorothy TrefonSVP & General Counsel
|
GrantCommon Stock | 1,315 | $129.78 | $170,660.70 |
DisclosureSEC source: 0001562180-25-001961 · primarydocument.xml · nonDerivative · entry 1 Capers Dorothy Trefon · CIK 0001905353 · SVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,197 F1 · shares: Reflects the acquisition of 1,315 shares of common stock upon vesting of performance-based stock units granted on March 1, 2022 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:12 UTC |
McGann Michael J.SVP & President Americas & MCS
|
Tax withholdingCommon Stock | 406 | $129.78 | $52,690.68 |
DisclosureSEC source: 0001562180-25-001958 · primarydocument.xml · nonDerivative · entry 5 McGann Michael J. · CIK 0001962070 · SVP & President Americas & MCS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,541 F6 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2022 (69), March 1, 2023 (178), and March 1, 2024 (159) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:12 UTC |
McGann Michael J.SVP & President Americas & MCS
|
Tax withholdingCommon Stock | 544 | $129.78 | $70,600.32 |
DisclosureSEC source: 0001562180-25-001958 · primarydocument.xml · nonDerivative · entry 4 McGann Michael J. · CIK 0001962070 · SVP & President Americas & MCS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,947 F5 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2022 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016). Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:12 UTC |
McGann Michael J.SVP & President Americas & MCS
|
GrantCommon Stock | 630 | $129.78 | $81,761.40 |
DisclosureSEC source: 0001562180-25-001958 · primarydocument.xml · nonDerivative · entry 3 McGann Michael J. · CIK 0001962070 · SVP & President Americas & MCS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,491 F4 · shares: Reflects the acquisition of 630 shares of common stock upon vesting of performance-based stock units granted on March 1, 2022 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:12 UTC |
McGann Michael J.SVP & President Americas & MCS
|
GrantCommon Stock | 630 | $129.78 | $81,761.40 |
DisclosureSEC source: 0001562180-25-001958 · primarydocument.xml · nonDerivative · entry 2 McGann Michael J. · CIK 0001962070 · SVP & President Americas & MCS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,861 F3 · shares: Reflects the acquisition of 630 shares of common stock upon vesting of performance-based stock units granted on March 1, 2022 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ROIC. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:12 UTC |
McGann Michael J.SVP & President Americas & MCS
|
GrantCommon Stock | 526 | $129.78 | $68,264.28 |
DisclosureSEC source: 0001562180-25-001958 · primarydocument.xml · nonDerivative · entry 1 McGann Michael J. · CIK 0001962070 · SVP & President Americas & MCS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,231 F1 · shares: Reflects the acquisition of 526 shares of common stock upon vesting of performance-based stock units granted on March 1, 2022 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:12 UTC |
Aulick RodneySVP & President, WSS
|
Tax withholdingCommon Stock | 166 | $129.78 | $21,543.48 |
DisclosureSEC source: 0001562180-25-001957 · primarydocument.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,135 F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2024 (166) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 21:16 UTC |
Aulick RodneySVP & President, WSS
|
Tax withholdingCommon Stock | 1,316 | $116.02 | $152,682.32 |
DisclosureSEC source: 0001562180-25-000106 · primarydocument.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,301 F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of: 1) restricted stock units granted on February 16, 2021 under the Evoqua Water Technologies 2017 Equity Plan (Evoqua Plan) that were converted to Xylem restricted stock units in connection with the Merger on May 24, 2023; 2) restricted stock units granted on December 31, 2021 under the Evoqua Plan that were converted to Xylem restricted stock units in connection with the Merger on May 24, 2023; and 3) restricted stock units granted on December 9, 2022 under the Evoqua Plan that were converted to Xylem restricted stock units in connection with the Merger on May 24, 2023 F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 21:24 UTC |
Aulick RodneySVP & President, WSS
|
Tax withholdingCommon Stock | 1,558 | $120.60 | $187,894.80 |
DisclosureSEC source: 0001562180-24-008448 · primarydocument.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,448 F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance share units granted on December 31, 2021 under the Evoqua Water Technologies 2017 Equity Plan (Evoqua Plan) that were converted to Xylem restricted stock units in connection with the Merger on May 24, 2023. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| November 01, 2024 Filed Dec 2, 2024 21:16 UTC |
Tretikov LilaDirector
|
SaleCommon Stock | 4 | $119.96 | $479.86 |
DisclosureSEC source: 0001562180-24-008036 · primarydocument.xml · nonDerivative · entry 2 Tretikov Lila · CIK 0001620654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,380 F1 · kind: The reporting person acknowledges that the transactions reported herein are matchable under Section 16(b) of the Securities Exchange Act of 1984, as amended (the "Exchange Act"). However, because the aggregate sales price for the reported transaction on November 1, 2024 was less than the aggregate purchase price for the reported transaction on October 22, 2024, no profit was realized by the reporting person and no amount is subject to disgorgement under Section 16(b) of the Exchange Act. Read SEC document |
| October 22, 2024 Filed Dec 2, 2024 21:16 UTC |
Tretikov LilaDirector
|
PurchaseCommon Stock | 4 | $131.98 | $527.92 |
DisclosureSEC source: 0001562180-24-008036 · primarydocument.xml · nonDerivative · entry 1 Tretikov Lila · CIK 0001620654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,384 Read SEC document |
| October 21, 2024 Filed Oct 23, 2024 16:15 UTC |
Emmerich MeredithSVP & Pres, AW
|
GrantStock Options (Right to buy) · Derivative | 33,138 | $132.54 Strike: $132.54 | $4,392,110.52 |
DisclosureSEC source: 0001562180-24-007435 · primarydocument.xml · derivative · entry 2 Emmerich Meredith · CIK 0002040538 · SVP & Pres, AW 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,138 Underlying: Common Stock · 33,138 shares Expires 2034-10-21 F2 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on October 21, 2025, October 21, 2026 and October 21, 2027. Read SEC document |
| October 21, 2024 Filed Oct 23, 2024 16:15 UTC |
Emmerich MeredithSVP & Pres, AW
|
GrantCommon Stock | 3,772 | $132.54 | $499,940.88 |
DisclosureSEC source: 0001562180-24-007435 · primarydocument.xml · nonDerivative · entry 1 Emmerich Meredith · CIK 0002040538 · SVP & Pres, AW 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,772 F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-half increments on October 21, 2025 and October 21, 2026. Read SEC document |
| September 18, 2024 Filed Sep 19, 2024 20:15 UTC |
Grogan William KSVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 4,253 | $132.86 | $565,053.58 |
DisclosureSEC source: 0001562180-24-006880 · primarydocument.xml · nonDerivative · entry 1 Grogan William K · CIK 0001694002 · SVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,457 F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on September 18, 2023, under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| September 09, 2024 Filed Sep 10, 2024 20:14 UTC |
Harker Victoria DDirector
|
SaleCommon Stock | 2,760 | $127.65 | $352,314.00 |
DisclosureSEC source: 0001562180-24-006754 · primarydocument.xml · nonDerivative · entry 1 Harker Victoria D · CIK 0001350579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,075 Read SEC document |
| August 27, 2024 Filed Aug 29, 2024 20:14 UTC |
Peribere Jerome ADirector
|
GiftCommon Stock | 1,839 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-006551 · primarydocument.xml · nonDerivative · entry 1 Peribere Jerome A · CIK 0001484527 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,736 F1 · shares: Reflects the transfer of shares of common stock from the reporting person's personal account to the Jerome A. Peribere 2016 Revocable Trust of which the reporting person is trustee. The reporting person and members of his immediate family are the sole beneficiaries of the trust. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| June 10, 2024 Filed Jun 11, 2024 20:18 UTC |
McShane Geri-MichelleVP, Controller & CAO
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 747 | $0.00 Strike: $74.07 | $0.00 |
DisclosureSEC source: 0001562180-24-004944 · primarydocument.xml · derivative · entry 5 McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 747 Underlying: Common Stock · 747 shares Expires 2029-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The February 20, 2019 option grant vested one third on February 20, 2020, February 20, 2021, and February 20, 2022. Read SEC document |
| June 10, 2024 Filed Jun 11, 2024 20:18 UTC |
McShane Geri-MichelleVP, Controller & CAO
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 1,019 | $0.00 Strike: $75.18 | $0.00 |
DisclosureSEC source: 0001562180-24-004944 · primarydocument.xml · derivative · entry 4 McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,019 Underlying: Common Stock · 1,019 shares Expires 2028-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The February 21, 2018 option grant vested one third on February 21, 2019, February 21, 2020, and February 21, 2021. Read SEC document |
| June 10, 2024 Filed Jun 11, 2024 20:18 UTC |
McShane Geri-MichelleVP, Controller & CAO
|
SaleCommon Stock | 2,278 | $138.63 | $315,799.14 |
DisclosureSEC source: 0001562180-24-004944 · primarydocument.xml · nonDerivative · entry 3 McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,536 F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 2,278 Shares were executed at a range of prices from $138.62 to $138.65. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| June 10, 2024 Filed Jun 11, 2024 20:18 UTC |
McShane Geri-MichelleVP, Controller & CAO
|
Exercise / conversionCommon Stock | 747 | $74.07 | $55,330.29 |
DisclosureSEC source: 0001562180-24-004944 · primarydocument.xml · nonDerivative · entry 2 McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2024 Filed Jun 11, 2024 20:18 UTC |
McShane Geri-MichelleVP, Controller & CAO
|
Exercise / conversionCommon Stock | 1,019 | $75.18 | $76,608.42 |
DisclosureSEC source: 0001562180-24-004944 · primarydocument.xml · nonDerivative · entry 1 McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,067 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 20:32 UTC |
Aulick RodneySVP & President, WSS
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 21,800 | $0.00 Strike: $49.23 | $0.00 |
DisclosureSEC source: 0001562180-24-004747 · primarydocument.xml · derivative · entry 3 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,800 Underlying: Common Stock · 21,800 shares Expires 2030-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The February 14, 2020 option grant vested one fourth on January 1, 2021, January 1, 2022, January 1, 2023, and January 1, 2024. Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 20:32 UTC |
Aulick RodneySVP & President, WSS
|
SaleCommon Stock | 21,800 | $139.01 | $3,030,387.48 |
DisclosureSEC source: 0001562180-24-004747 · primarydocument.xml · nonDerivative · entry 2 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,287 F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 21,800 Shares were executed at a range of prices from $139.00 to $139.07. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.